Leishmania mexicana Induces Limited Recruitment and Activation of Monocytes and Monocyte-Derived Dendritic Cells Early during Infection

PLoS Neglected Tropical Diseases

Volumn 6, Issue 10, 2012, Pages

  Petritus, Patricia M ^a   Manzoni de Almeida, Daniel ^a,b   Gimblet, Ciara ^a   Gonzalez Lombana, Claudia ^a   Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD11 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ALPHA ANTIBODY; LYMPHOCYTE ANTIGEN; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL DIFFERENTIATION; CELL MIGRATION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; LEISHMANIASIS; LYMPH NODE; MONOCYTE; MOUSE; NONHUMAN; TH1 CELL;

ANIMALS; DENDRITIC CELLS; EAR; FEMALE; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED C57BL; MONOCYTES; TH1 CELLS;

EID: 84869034909     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001858     Document Type: Article

References (43)

1. McMahon-Pratt D, Alexander J, (2004) Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol Rev 201: 206-224.
2. Reiner SL, Locksley RM, (1995) The regulation of immunity to Leishmania major. Annual review of immunology 13: 151-177.
3. Sacks D, Noben-Trauth N, (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nature reviews Immunology 2: 845-858.
4. Alexander J, Kaye PM, (1985) Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections. Clinical and experimental immunology 61: 674-682.
5. Buxbaum LU, Denise H, Coombs GH, Alexander J, Mottram JC, et al. (2003) Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity. journal of immunology 171: 3711-3717.
6. Buxbaum LU, Scott P, (2005) Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions. Infection and immunity 73: 2101-2108.
7. Ji J, Sun J, Soong L, (2003) Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect Immun 71: 4278-4288.
8. Afonso LC, Scott P, (1993) Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun 61: 2952-2959.
9. Jones DE, Buxbaum LU, Scott P, (2000) IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J Immunol 165: 364-372.
10. Qi H, Popov V, Soong L, (2001) Leishmania amazonensis-dendritic cell interactions in vitro and the priming of parasite-specific CD4(+) T cells in vivo. J Immunol 167: 4534-4542.
11. Bennett CL, Misslitz A, Colledge L, Aebischer T, Blackburn CC, (2001) Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes. Eur J Immunol 31: 876-883.
12. Weinheber N, Wolfram M, Harbecke D, Aebischer T, (1998) Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production. Eur J Immunol 28: 2467-2477.
13. Alexander J, Satoskar AR, Russell DG, (1999) Leishmania species: models of intracellular parasitism. J Cell Sci 112 Pt 18: 2993-3002.
14. Rodriguez-Sosa M, Monteforte GM, Satoskar AR, (2001) Susceptibility to Leishmania mexicana infection is due to the inability to produce IL-12 rather than lack of IL-12 responsiveness. Immunol Cell Biol 79: 320-322.
15. Satoskar A, Bluethmann H, Alexander J, (1995) Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect Immun 63: 4894-4899.
16. Stamm LM, Raisanen-Sokolowski A, Okano M, Russell ME, David JR, et al. (1998) Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. J Immunol 161: 6180-6188.
17. Buxbaum LU, Uzonna JE, Goldschmidt MH, Scott P, (2002) Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent. Eur J Immunol 32: 3206-3215.
18. Shi C, Pamer EG, (2011) Monocyte recruitment during infection and inflammation. Nature reviews Immunology 11: 762-774.
19. Serbina NV, Jia T, Hohl TM, Pamer EG, (2008) Monocyte-mediated defense against microbial pathogens. Annual review of immunology 26: 421-452.
20. Auffray C, Sieweke MH, Geissmann F, (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annual review of immunology 27: 669-692.
21. Rivollier A, He J, Kole A, Valatas V, Kelsall BL, (2012) Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med 209: 139-155.
22. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG, (2003) TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19: 59-70.
23. De Trez C, Magez S, Akira S, Ryffel B, Carlier Y, et al. (2009) iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathog 5: e1000494.
24. Leon B, Lopez-Bravo M, Ardavin C, (2007) Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26: 519-531.
25. Carvalho LP, Petritus PM, Trochtenberg AL, Zaph C, Hill DA, et al. (2011) Lymph Node Hypertrophy following Leishmania major Infection Is Dependent on TLR9. J Immunol.
26. Spath GF, Beverley SM, (2001) A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 99: 97-103.
27. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92.
28. Solovjov DA, Pluskota E, Plow EF, (2005) Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2. J Biol Chem 280: 1336-1345.
29. Banchereau J, Steinman RM, (1998) Dendritic cells and the control of immunity. Nature 392: 245-252.
30. Hsu AC, Scott P, (2007) Leishmania mexicana infection induces impaired lymph node expansion and Th1 cell differentiation despite normal T cell proliferation. J Immunol 179: 8200-8207.
31. Leon B, Martinez del Hoyo G, Parrillas V, Vargas HH, Sanchez-Mateos P, et al. (2004) Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8- and CD8+ splenic dendritic cells. Blood 103: 2668-2676.
32. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A, (2001) Interleukin-10 and the interleukin-10 receptor. Annual review of immunology 19: 683-765.
33. Bosschaerts T, Guilliams M, Stijlemans B, Morias Y, Engel D, et al. (2010) Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling. PLoS Pathog 6: e1001045.
34. Satoskar A, Alexander J, (1995) Sex-determined susceptibility and differential IFN-gamma and TNF-alpha mRNA expression in DBA/2 mice infected with Leishmania mexicana. Immunology 84: 1-4.
35. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK, (1993) Recombinant interleukin 12 cures mice infected with Leishmania major. The Journal of experimental medicine 177: 1505-1509.
36. Heinzel FP, (1994) Interleukin 12 and the regulation of CD4+ T-cell subset responses during murine Leishmaniasis. Parasitology today 10: 190-192.
37. Afonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, et al. (1994) The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263: 235-237.
38. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, et al. (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 177: 1797-1802.
39. Goncalves R, Zhang X, Cohen H, Debrabant A, Mosser DM, (2011) Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection. J Exp Med 208: 1253-1265.
40. Serbina NV, Pamer EG, (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nature immunology 7: 311-317.
41. Dunay IR, Damatta RA, Fux B, Presti R, Greco S, et al. (2008) Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 29: 306-317.
42. Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, et al. (2000) CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. J Exp Med 192: 205-218.
43. Jimenez F, Quinones MP, Martinez HG, Estrada CA, Clark K, et al. (2010) CCR2 plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-kappa B. J Immunol 184: 5571-5581.